Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON)
Abstract The present analysis was intended to evaluate the real-world management of peripheral arterial disease (PAD) in Asia, and to explore cardiovascular events in patients with PAD undergoing antiplatelet therapy over 2 years of follow-up. The Surveillance of cardiovascular Events in Antiplatele...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6f13189ec02495cb7f58b2188acd9fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c6f13189ec02495cb7f58b2188acd9fe |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c6f13189ec02495cb7f58b2188acd9fe2021-12-02T11:53:02ZTwo-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON)10.1038/s41598-017-06597-y2045-2322https://doaj.org/article/c6f13189ec02495cb7f58b2188acd9fe2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06597-yhttps://doaj.org/toc/2045-2322Abstract The present analysis was intended to evaluate the real-world management of peripheral arterial disease (PAD) in Asia, and to explore cardiovascular events in patients with PAD undergoing antiplatelet therapy over 2 years of follow-up. The Surveillance of cardiovascular Events in Antiplatelet-treated arteriosclerosis Obliterans patients in JapaN (SEASON) registry is a prospective observational multicenter study of cardiovascular events in antiplatelet-treated patients with PAD in Japan. The SEASON registry included 11,375 patients who were scheduled to receive treatment for PAD. Two analysis populations were defined: a real-world population (RWP; n = 10,322) and a definite PAD population (DPP; n = 3992) who had ankle-brachial pressure index (ABPI) <0.9 and intermittent claudication, or a history of lower limb revascularization. The primary outcome measure was the rate of the composite of cerebrovascular, cardiovascular, and peripheral vascular events. The composite event rates (95% confidence interval) were 3.28 (3.00–3.57) and 5.71 (5.13–6.34) events per 100 patient-years in the RWP and DPP groups, respectively. Fontaine IV classification and ABPI <0.4 at baseline were both identified as strong risk factors for vascular events. These findings contribute to understanding the situation for real-world patients with PAD receiving antiplatelet therapy.Yukihito HigashiTetsuro MiyataHiroshi ShigematsuHideki OrigasaMasatoshi FujitaHiroshi MatsuoHiroaki NaritomiHiroaki MatsudaMasahide NakajimaHideto AwanoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Yukihito Higashi Tetsuro Miyata Hiroshi Shigematsu Hideki Origasa Masatoshi Fujita Hiroshi Matsuo Hiroaki Naritomi Hiroaki Matsuda Masahide Nakajima Hideto Awano Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON) |
description |
Abstract The present analysis was intended to evaluate the real-world management of peripheral arterial disease (PAD) in Asia, and to explore cardiovascular events in patients with PAD undergoing antiplatelet therapy over 2 years of follow-up. The Surveillance of cardiovascular Events in Antiplatelet-treated arteriosclerosis Obliterans patients in JapaN (SEASON) registry is a prospective observational multicenter study of cardiovascular events in antiplatelet-treated patients with PAD in Japan. The SEASON registry included 11,375 patients who were scheduled to receive treatment for PAD. Two analysis populations were defined: a real-world population (RWP; n = 10,322) and a definite PAD population (DPP; n = 3992) who had ankle-brachial pressure index (ABPI) <0.9 and intermittent claudication, or a history of lower limb revascularization. The primary outcome measure was the rate of the composite of cerebrovascular, cardiovascular, and peripheral vascular events. The composite event rates (95% confidence interval) were 3.28 (3.00–3.57) and 5.71 (5.13–6.34) events per 100 patient-years in the RWP and DPP groups, respectively. Fontaine IV classification and ABPI <0.4 at baseline were both identified as strong risk factors for vascular events. These findings contribute to understanding the situation for real-world patients with PAD receiving antiplatelet therapy. |
format |
article |
author |
Yukihito Higashi Tetsuro Miyata Hiroshi Shigematsu Hideki Origasa Masatoshi Fujita Hiroshi Matsuo Hiroaki Naritomi Hiroaki Matsuda Masahide Nakajima Hideto Awano |
author_facet |
Yukihito Higashi Tetsuro Miyata Hiroshi Shigematsu Hideki Origasa Masatoshi Fujita Hiroshi Matsuo Hiroaki Naritomi Hiroaki Matsuda Masahide Nakajima Hideto Awano |
author_sort |
Yukihito Higashi |
title |
Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON) |
title_short |
Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON) |
title_full |
Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON) |
title_fullStr |
Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON) |
title_full_unstemmed |
Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON) |
title_sort |
two-year follow-up of vascular events in peripheral arterial disease treated with antiplatelet agents: a prospective observational multicenter cohort study (season) |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/c6f13189ec02495cb7f58b2188acd9fe |
work_keys_str_mv |
AT yukihitohigashi twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT tetsuromiyata twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT hiroshishigematsu twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT hidekiorigasa twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT masatoshifujita twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT hiroshimatsuo twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT hiroakinaritomi twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT hiroakimatsuda twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT masahidenakajima twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason AT hidetoawano twoyearfollowupofvasculareventsinperipheralarterialdiseasetreatedwithantiplateletagentsaprospectiveobservationalmulticentercohortstudyseason |
_version_ |
1718394892669943808 |